Show simple item record

dc.contributor.authorELVERDİ, Tuğrul
dc.contributor.authorBEŞIŞIK, Sevgi
dc.contributor.authorOSMANBAŞOĞLU, Emre
dc.contributor.authorTEMURHAN, SONAY
dc.contributor.authorAKGÜL, Sebahat
dc.contributor.authorAYDIN, Filiz
dc.contributor.authorNALÇACI, Meliha
dc.date.accessioned2021-03-03T17:46:54Z
dc.date.available2021-03-03T17:46:54Z
dc.identifier.citationELVERDİ T., TEMURHAN S., OSMANBAŞOĞLU E., AKGÜL S., AYDIN F., NALÇACI M., BEŞIŞIK S., "Elevated Thymidine Kinase Levels (TKI)may identify patients at high risk of disease progression in newly diagnosed multiple myeloma.", 4 th International Congress on Leukemia Lymphoma Myeloma, İstanbul, Türkiye, 22 - 25 Mayıs 2013, ss.310-311
dc.identifier.othervv_1032021
dc.identifier.otherav_4b6847c4-73f7-49d2-83fd-6ce0bc2f35b3
dc.identifier.urihttp://hdl.handle.net/20.500.12627/54118
dc.language.isoeng
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.titleElevated Thymidine Kinase Levels (TKI)may identify patients at high risk of disease progression in newly diagnosed multiple myeloma.
dc.typeBildiri
dc.contributor.departmentİstanbul Üniversitesi , İstanbul Tıp Fakültesi , Tıbbi Biyoloji Anabilim Dalı
dc.contributor.firstauthorID421824


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record